Asia · Regional markets · Business Standard

Alembic Pharma shares hit 20% upper circuit after 81% YoY rise in Q2 PAT

Published by Business Standard · India 2 h ago

Alembic Pharma's revenue from operations increased by 36 per cent YoY to ₹2,603 crore during the said period from ₹1,910 crore a year ago.

Read the full article on Business Standard Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.business-standard.com)

Also worth reading

The Business Times

Mainstream car COE charges to new record, outstrips luxury category as car show drives demand

25 rising startups in the Philippines

The Straits Times Business

Google to invest US$15 billion in Malaysia in 2027 and 2028

The Edge Malaysia

CIMB Group Holdings Bhd

Insignia Ventures in talks to invest in Indonesian consumer brand URU

Rice imports brought in before region feels worst of El Niño